Page last updated: 2024-11-10

5,6-dehydrokawain

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

5,6-dehydrokawain: from Alpinia speciosa rhizoma; RN given for cpd without isomeric designation; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
AlpiniagenusA plant genus of the family ZINGIBERACEAE. Members contain galangin, yakuchinone-A, and diarylheptanoids.[MeSH]ZingiberaceaeA plant family of the order Zingiberales, subclass Zingiberidae, class Liliopsida. It includes plants which have both flavoring and medicinal properties such as GINGER; turmeric (CURCUMA), and cardamom (ELETTARIA).[MeSH]
Alpinia speciosaspecies[no description available]ZingiberaceaeA plant family of the order Zingiberales, subclass Zingiberidae, class Liliopsida. It includes plants which have both flavoring and medicinal properties such as GINGER; turmeric (CURCUMA), and cardamom (ELETTARIA).[MeSH]
Alpinia speciosaspecies[no description available]ZingiberaceaeA plant family of the order Zingiberales, subclass Zingiberidae, class Liliopsida. It includes plants which have both flavoring and medicinal properties such as GINGER; turmeric (CURCUMA), and cardamom (ELETTARIA).[MeSH]

Cross-References

ID SourceID
PubMed CID5273621
CHEMBL ID254218
CHEBI ID1995
SCHEMBL ID236641
MeSH IDM0148495

Synonyms (64)

Synonym
4-methoxy-6-(2-phenylethenyl)-2h-pyran-2-one
nsc68686
nsc-68686
4-methoxy-6-[(e)-styryl]pyran-2-one
2h-pyran-2-one, 4-methoxy-6-[(e)-2-phenylethenyl]-
2h-pyran-2-one, 4-methoxy-6-(2-phenylethenyl)-, (e)-
nsc 112161
2h-pyran-2-one, 4-methoxy-6-styryl-, (e)-
demethoxyyangonin
(e)-4-methoxy-6-(2-phenylethenyl)-2h-pyran-2-one
4-methoxy-6-styryl-2h-pyran-2-one
nsc-112161
nsc112161
26531-51-1
NCGC00091904-01
desmethoxyyangonin
15345-89-8
5,6-dehydrokawain
C09925
DMY ,
4-methoxy-6-[(e)-2-phenylvinyl]-2h-pyran-2-one
chebi:1995 ,
CHEMBL254218
5,6-dehydrokawin
4-methoxy-6-[(e)-2-phenylethenyl]pyran-2-one
A809430
NCGC00091904-02
dtxcid2013390
dtxsid4033390 ,
cas-15345-89-8
tox21_200296
NCGC00257850-01
1952-41-6
f2mbq8qrun ,
nsc 68686
ccris 9369
2h-pyran-2-one, 4-methoxy-6-(2-phenylethenyl)-
unii-f2mbq8qrun
trans-5,6-dehydrokawain
4-methoxy-6-[(1e)-2-phenylethenyl]-2h-pyran-2-one
desmethoxy yangonin
(e)-4-methoxy-6-styryl-2h-pyran-2-one
5,6-dehydrokavain
AKOS015896811
yangonin, demethoxy-
2h-pyran-2-one, 4-methoxy-6-((1e)-2-phenylethenyl)-
SCHEMBL236641
CCG-208562
CS-4242
DKKJNZYHGRUXBS-BQYQJAHWSA-N
2h-pyran-2-one, 4-methoxy-6-[(1e)-2-phenylethenyl]-
AC-34590
5,6-dihydro-5-hydroxy-6-methyl-2h-pyran-2-one
HY-N0918
2h-pyran-2-one, 4-methoxy-6-(2-phenylethenyl)-, (e)- (9ci)
4-methoxy-6-[(e)-2-phenylethenyl]-2h-pyran-2-one
desmethoxyyangonin, analytical standard
SR-05000002195-2
sr-05000002195
AS-68696
4-methoxy-6-styryl-(e)-2h-pyran-2-one
4-methoxy-6-(2-phenylethenyl)-(e)-2h-pyran-2-one
Q5264611
mfcd00221730

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"To examine the bioavailability of kavalactones in vitro and the possible differences in their bioavailability because of variations in either chemical structure or the method of extraction used."( Permeability studies of Kavalactones using a Caco-2 cell monolayer model.
Blanchfield, JT; Bone, KM; Lehmann, RP; Matthias, A; Penman, KG; Toth, I, 2007
)
0.34
"Caco-2 cell monolayers were used to determine the potential bioavailability of kavalactones."( Permeability studies of Kavalactones using a Caco-2 cell monolayer model.
Blanchfield, JT; Bone, KM; Lehmann, RP; Matthias, A; Penman, KG; Toth, I, 2007
)
0.34
" Not all differences in their bioavailability can be related to kavalactone structural differences as it appears that bioavailability may also be affected by co-extracted compounds."( Permeability studies of Kavalactones using a Caco-2 cell monolayer model.
Blanchfield, JT; Bone, KM; Lehmann, RP; Matthias, A; Penman, KG; Toth, I, 2007
)
0.34
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
aromatic etherAny ether in which the oxygen is attached to at least one aryl substituent.
2-pyranonesA pyranone based on the structure of 2H-pyran-2-one and its substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (48)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency7.34770.007215.758889.3584AID1224835
pregnane X receptorRattus norvegicus (Norway rat)Potency44.66840.025127.9203501.1870AID651751
RAR-related orphan receptor gammaMus musculus (house mouse)Potency1.81750.006038.004119,952.5996AID1159521; AID1159523
GLI family zinc finger 3Homo sapiens (human)Potency2.57350.000714.592883.7951AID1259368; AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency13.04880.000221.22318,912.5098AID1259243; AID1259247; AID588516; AID743036; AID743040; AID743042; AID743054
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency31.62280.011212.4002100.0000AID1030
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency3.72800.001022.650876.6163AID1224838; AID1224839; AID1224893
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency1.16360.003041.611522,387.1992AID1159552; AID1159553; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency25.11890.000817.505159.3239AID588544
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency5.00090.001530.607315,848.9004AID1224841; AID1224842; AID1224848; AID1224849; AID1259401; AID1259403
farnesoid X nuclear receptorHomo sapiens (human)Potency28.18380.375827.485161.6524AID588526
pregnane X nuclear receptorHomo sapiens (human)Potency7.95300.005428.02631,258.9301AID1346982; AID720659
estrogen nuclear receptor alphaHomo sapiens (human)Potency8.53510.000229.305416,493.5996AID1259244; AID1259248; AID743069; AID743075; AID743079; AID743080; AID743091
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency38.18360.001024.504861.6448AID588534; AID743212
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency63.77780.023723.228263.5986AID743222
aryl hydrocarbon receptorHomo sapiens (human)Potency5.08890.000723.06741,258.9301AID651777; AID743085; AID743122
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency0.50240.001723.839378.1014AID743083
cellular tumor antigen p53 isoform aHomo sapiens (human)Potency12.58930.316212.443531.6228AID902
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1Homo sapiens (human)Potency11.22020.001815.663839.8107AID894
histone deacetylase 9 isoform 3Homo sapiens (human)Potency11.69640.037617.082361.1927AID1259364; AID1259388
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency26.02550.000627.21521,122.0200AID651741; AID720636; AID743202; AID743219
survival motor neuron protein isoform dHomo sapiens (human)Potency8.91250.125912.234435.4813AID1458
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency15.84890.031610.279239.8107AID884; AID885
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency0.89340.001557.789015,848.9004AID1259244
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency0.89340.001551.739315,848.9004AID1259244
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Nuclear receptor ROR-gammaHomo sapiens (human)Potency1.49600.026622.448266.8242AID651802
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
GABA theta subunitRattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
ATPase family AAA domain-containing protein 5Homo sapiens (human)Potency8.75680.011917.942071.5630AID651632; AID720516
Ataxin-2Homo sapiens (human)Potency7.09680.011912.222168.7989AID651632
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
BH3-interacting domain death agonistHomo sapiens (human)Ki33.00000.20004.20008.6000AID1504724
Bcl-2-like protein 1Homo sapiens (human)Ki23.00000.00000.45819.0000AID1504723
Induced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)Ki33.00000.00101.46539.5400AID1504724
Bcl-2 homologous antagonist/killerHomo sapiens (human)Ki23.00000.00102.71829.0000AID1504723
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (143)

Processvia Protein(s)Taxonomy
negative regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
xenobiotic metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of glucose metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of steroid metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
intracellular receptor signaling pathwayNuclear receptor ROR-gammaHomo sapiens (human)
circadian regulation of gene expressionNuclear receptor ROR-gammaHomo sapiens (human)
cellular response to sterolNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of circadian rhythmNuclear receptor ROR-gammaHomo sapiens (human)
regulation of fat cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of DNA-templated transcriptionNuclear receptor ROR-gammaHomo sapiens (human)
adipose tissue developmentNuclear receptor ROR-gammaHomo sapiens (human)
T-helper 17 cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
release of cytochrome c from mitochondriaBH3-interacting domain death agonistHomo sapiens (human)
protein targeting to mitochondrionBH3-interacting domain death agonistHomo sapiens (human)
extrinsic apoptotic signaling pathway via death domain receptorsBH3-interacting domain death agonistHomo sapiens (human)
positive regulation of mitochondrial membrane potentialBH3-interacting domain death agonistHomo sapiens (human)
positive regulation of protein-containing complex assemblyBH3-interacting domain death agonistHomo sapiens (human)
regulation of T cell proliferationBH3-interacting domain death agonistHomo sapiens (human)
signal transduction in response to DNA damageBH3-interacting domain death agonistHomo sapiens (human)
mitochondrial ATP synthesis coupled electron transportBH3-interacting domain death agonistHomo sapiens (human)
positive regulation of apoptotic processBH3-interacting domain death agonistHomo sapiens (human)
regulation of epithelial cell proliferationBH3-interacting domain death agonistHomo sapiens (human)
neuron apoptotic processBH3-interacting domain death agonistHomo sapiens (human)
protein-containing complex assemblyBH3-interacting domain death agonistHomo sapiens (human)
establishment of protein localization to membraneBH3-interacting domain death agonistHomo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaBH3-interacting domain death agonistHomo sapiens (human)
hepatocyte apoptotic processBH3-interacting domain death agonistHomo sapiens (human)
mitochondrial outer membrane permeabilizationBH3-interacting domain death agonistHomo sapiens (human)
supramolecular fiber organizationBH3-interacting domain death agonistHomo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damageBH3-interacting domain death agonistHomo sapiens (human)
regulation of G1/S transition of mitotic cell cycleBH3-interacting domain death agonistHomo sapiens (human)
positive regulation of fibroblast apoptotic processBH3-interacting domain death agonistHomo sapiens (human)
positive regulation of extrinsic apoptotic signaling pathwayBH3-interacting domain death agonistHomo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayBH3-interacting domain death agonistHomo sapiens (human)
apoptotic mitochondrial changesBH3-interacting domain death agonistHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processBH3-interacting domain death agonistHomo sapiens (human)
response to cytokineBcl-2-like protein 1Homo sapiens (human)
negative regulation of apoptotic processBcl-2-like protein 1Homo sapiens (human)
negative regulation of extrinsic apoptotic signaling pathway via death domain receptorsBcl-2-like protein 1Homo sapiens (human)
ovarian follicle developmentBcl-2-like protein 1Homo sapiens (human)
in utero embryonic developmentBcl-2-like protein 1Homo sapiens (human)
release of cytochrome c from mitochondriaBcl-2-like protein 1Homo sapiens (human)
endocytosisBcl-2-like protein 1Homo sapiens (human)
germ cell developmentBcl-2-like protein 1Homo sapiens (human)
spermatogenesisBcl-2-like protein 1Homo sapiens (human)
male gonad developmentBcl-2-like protein 1Homo sapiens (human)
apoptotic mitochondrial changesBcl-2-like protein 1Homo sapiens (human)
fertilizationBcl-2-like protein 1Homo sapiens (human)
regulation of cytokinesisBcl-2-like protein 1Homo sapiens (human)
positive regulation of mononuclear cell proliferationBcl-2-like protein 1Homo sapiens (human)
ectopic germ cell programmed cell deathBcl-2-like protein 1Homo sapiens (human)
regulation of growthBcl-2-like protein 1Homo sapiens (human)
negative regulation of apoptotic processBcl-2-like protein 1Homo sapiens (human)
negative regulation of neuron apoptotic processBcl-2-like protein 1Homo sapiens (human)
dendritic cell proliferationBcl-2-like protein 1Homo sapiens (human)
response to cycloheximideBcl-2-like protein 1Homo sapiens (human)
regulation of mitochondrial membrane permeabilityBcl-2-like protein 1Homo sapiens (human)
epithelial cell proliferationBcl-2-like protein 1Homo sapiens (human)
negative regulation of developmental processBcl-2-like protein 1Homo sapiens (human)
neuron apoptotic processBcl-2-like protein 1Homo sapiens (human)
defense response to virusBcl-2-like protein 1Homo sapiens (human)
regulation of mitochondrial membrane potentialBcl-2-like protein 1Homo sapiens (human)
cellular response to amino acid stimulusBcl-2-like protein 1Homo sapiens (human)
cellular response to alkaloidBcl-2-like protein 1Homo sapiens (human)
cellular response to gamma radiationBcl-2-like protein 1Homo sapiens (human)
apoptotic process in bone marrow cellBcl-2-like protein 1Homo sapiens (human)
negative regulation of release of cytochrome c from mitochondriaBcl-2-like protein 1Homo sapiens (human)
dendritic cell apoptotic processBcl-2-like protein 1Homo sapiens (human)
hepatocyte apoptotic processBcl-2-like protein 1Homo sapiens (human)
negative regulation of execution phase of apoptosisBcl-2-like protein 1Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damageBcl-2-like protein 1Homo sapiens (human)
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathwayBcl-2-like protein 1Homo sapiens (human)
negative regulation of protein localization to plasma membraneBcl-2-like protein 1Homo sapiens (human)
negative regulation of reproductive processBcl-2-like protein 1Homo sapiens (human)
negative regulation of dendritic cell apoptotic processBcl-2-like protein 1Homo sapiens (human)
negative regulation of extrinsic apoptotic signaling pathway in absence of ligandBcl-2-like protein 1Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathwayBcl-2-like protein 1Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damageBcl-2-like protein 1Homo sapiens (human)
extrinsic apoptotic signaling pathway in absence of ligandBcl-2-like protein 1Homo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processBcl-2-like protein 1Homo sapiens (human)
DNA damage responseInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
response to cytokineInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
cell fate determinationInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
negative regulation of autophagyInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
cellular homeostasisInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
positive regulation of apoptotic processInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
negative regulation of apoptotic processInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
protein transmembrane transportInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
extrinsic apoptotic signaling pathway in absence of ligandInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathwayInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
negative regulation of anoikisInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
negative regulation of extrinsic apoptotic signaling pathway in absence of ligandInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
mitochondrial fusionInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
release of cytochrome c from mitochondriaInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damageInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
B cell homeostasisBcl-2 homologous antagonist/killerHomo sapiens (human)
B cell apoptotic processBcl-2 homologous antagonist/killerHomo sapiens (human)
release of cytochrome c from mitochondriaBcl-2 homologous antagonist/killerHomo sapiens (human)
blood vessel remodelingBcl-2 homologous antagonist/killerHomo sapiens (human)
myeloid cell homeostasisBcl-2 homologous antagonist/killerHomo sapiens (human)
B cell negative selectionBcl-2 homologous antagonist/killerHomo sapiens (human)
apoptotic processBcl-2 homologous antagonist/killerHomo sapiens (human)
mitochondrial fusionBcl-2 homologous antagonist/killerHomo sapiens (human)
negative regulation of cell population proliferationBcl-2 homologous antagonist/killerHomo sapiens (human)
response to xenobiotic stimulusBcl-2 homologous antagonist/killerHomo sapiens (human)
response to fungusBcl-2 homologous antagonist/killerHomo sapiens (human)
response to mycotoxinBcl-2 homologous antagonist/killerHomo sapiens (human)
response to UV-CBcl-2 homologous antagonist/killerHomo sapiens (human)
establishment or maintenance of transmembrane electrochemical gradientBcl-2 homologous antagonist/killerHomo sapiens (human)
response to gamma radiationBcl-2 homologous antagonist/killerHomo sapiens (human)
positive regulation of calcium ion transport into cytosolBcl-2 homologous antagonist/killerHomo sapiens (human)
negative regulation of gene expressionBcl-2 homologous antagonist/killerHomo sapiens (human)
response to organic cyclic compoundBcl-2 homologous antagonist/killerHomo sapiens (human)
endocrine pancreas developmentBcl-2 homologous antagonist/killerHomo sapiens (human)
animal organ regenerationBcl-2 homologous antagonist/killerHomo sapiens (human)
positive regulation of protein-containing complex assemblyBcl-2 homologous antagonist/killerHomo sapiens (human)
endoplasmic reticulum calcium ion homeostasisBcl-2 homologous antagonist/killerHomo sapiens (human)
negative regulation of endoplasmic reticulum calcium ion concentrationBcl-2 homologous antagonist/killerHomo sapiens (human)
negative regulation of peptidyl-serine phosphorylationBcl-2 homologous antagonist/killerHomo sapiens (human)
cellular response to unfolded proteinBcl-2 homologous antagonist/killerHomo sapiens (human)
cellular response to UVBcl-2 homologous antagonist/killerHomo sapiens (human)
limb morphogenesisBcl-2 homologous antagonist/killerHomo sapiens (human)
response to hydrogen peroxideBcl-2 homologous antagonist/killerHomo sapiens (human)
positive regulation of apoptotic processBcl-2 homologous antagonist/killerHomo sapiens (human)
fibroblast apoptotic processBcl-2 homologous antagonist/killerHomo sapiens (human)
response to ethanolBcl-2 homologous antagonist/killerHomo sapiens (human)
positive regulation of proteolysisBcl-2 homologous antagonist/killerHomo sapiens (human)
regulation of mitochondrial membrane permeabilityBcl-2 homologous antagonist/killerHomo sapiens (human)
post-embryonic camera-type eye morphogenesisBcl-2 homologous antagonist/killerHomo sapiens (human)
epithelial cell proliferationBcl-2 homologous antagonist/killerHomo sapiens (human)
establishment of localization in cellBcl-2 homologous antagonist/killerHomo sapiens (human)
regulation of cell cycleBcl-2 homologous antagonist/killerHomo sapiens (human)
regulation of mitochondrial membrane potentialBcl-2 homologous antagonist/killerHomo sapiens (human)
vagina developmentBcl-2 homologous antagonist/killerHomo sapiens (human)
calcium ion transport into cytosolBcl-2 homologous antagonist/killerHomo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressBcl-2 homologous antagonist/killerHomo sapiens (human)
thymocyte apoptotic processBcl-2 homologous antagonist/killerHomo sapiens (human)
cellular response to mechanical stimulusBcl-2 homologous antagonist/killerHomo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaBcl-2 homologous antagonist/killerHomo sapiens (human)
negative regulation of release of cytochrome c from mitochondriaBcl-2 homologous antagonist/killerHomo sapiens (human)
apoptotic signaling pathwayBcl-2 homologous antagonist/killerHomo sapiens (human)
intrinsic apoptotic signaling pathwayBcl-2 homologous antagonist/killerHomo sapiens (human)
activation of cysteine-type endopeptidase activityBcl-2 homologous antagonist/killerHomo sapiens (human)
positive regulation of endoplasmic reticulum unfolded protein responseBcl-2 homologous antagonist/killerHomo sapiens (human)
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathwayBcl-2 homologous antagonist/killerHomo sapiens (human)
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathwayBcl-2 homologous antagonist/killerHomo sapiens (human)
apoptotic process involved in blood vessel morphogenesisBcl-2 homologous antagonist/killerHomo sapiens (human)
positive regulation of IRE1-mediated unfolded protein responseBcl-2 homologous antagonist/killerHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processBcl-2 homologous antagonist/killerHomo sapiens (human)
extrinsic apoptotic signaling pathway in absence of ligandBcl-2 homologous antagonist/killerHomo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damageBcl-2 homologous antagonist/killerHomo sapiens (human)
cell population proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of B cell proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
nuclear DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
signal transduction in response to DNA damageATPase family AAA domain-containing protein 5Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
isotype switchingATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of isotype switching to IgG isotypesATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloadingATPase family AAA domain-containing protein 5Homo sapiens (human)
regulation of mitotic cell cycle phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of cell cycle G2/M phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of receptor internalizationAtaxin-2Homo sapiens (human)
regulation of translationAtaxin-2Homo sapiens (human)
RNA metabolic processAtaxin-2Homo sapiens (human)
P-body assemblyAtaxin-2Homo sapiens (human)
stress granule assemblyAtaxin-2Homo sapiens (human)
RNA transportAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (34)

Processvia Protein(s)Taxonomy
RNA polymerase II cis-regulatory region sequence-specific DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
protein bindingNuclear receptor ROR-gammaHomo sapiens (human)
oxysterol bindingNuclear receptor ROR-gammaHomo sapiens (human)
zinc ion bindingNuclear receptor ROR-gammaHomo sapiens (human)
ligand-activated transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
sequence-specific double-stranded DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
nuclear receptor activityNuclear receptor ROR-gammaHomo sapiens (human)
death receptor bindingBH3-interacting domain death agonistHomo sapiens (human)
protein bindingBH3-interacting domain death agonistHomo sapiens (human)
ubiquitin protein ligase bindingBH3-interacting domain death agonistHomo sapiens (human)
protein bindingBcl-2-like protein 1Homo sapiens (human)
protein kinase bindingBcl-2-like protein 1Homo sapiens (human)
identical protein bindingBcl-2-like protein 1Homo sapiens (human)
BH3 domain bindingBcl-2-like protein 1Homo sapiens (human)
BH domain bindingBcl-2-like protein 1Homo sapiens (human)
protein bindingInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
protein transmembrane transporter activityInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
protein heterodimerization activityInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
BH3 domain bindingInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
channel activityInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
BH domain bindingInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
molecular_functionBcl-2 homologous antagonist/killerHomo sapiens (human)
protein bindingBcl-2 homologous antagonist/killerHomo sapiens (human)
porin activityBcl-2 homologous antagonist/killerHomo sapiens (human)
heat shock protein bindingBcl-2 homologous antagonist/killerHomo sapiens (human)
identical protein bindingBcl-2 homologous antagonist/killerHomo sapiens (human)
protein homodimerization activityBcl-2 homologous antagonist/killerHomo sapiens (human)
transmembrane transporter bindingBcl-2 homologous antagonist/killerHomo sapiens (human)
protein-containing complex bindingBcl-2 homologous antagonist/killerHomo sapiens (human)
metal ion bindingBcl-2 homologous antagonist/killerHomo sapiens (human)
protein heterodimerization activityBcl-2 homologous antagonist/killerHomo sapiens (human)
protein-folding chaperone bindingBcl-2 homologous antagonist/killerHomo sapiens (human)
BH domain bindingBcl-2 homologous antagonist/killerHomo sapiens (human)
protein bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP hydrolysis activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloader activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
RNA bindingAtaxin-2Homo sapiens (human)
epidermal growth factor receptor bindingAtaxin-2Homo sapiens (human)
protein bindingAtaxin-2Homo sapiens (human)
mRNA bindingAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (25)

Processvia Protein(s)Taxonomy
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
nucleoplasmNuclear receptor ROR-gammaHomo sapiens (human)
nuclear bodyNuclear receptor ROR-gammaHomo sapiens (human)
chromatinNuclear receptor ROR-gammaHomo sapiens (human)
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
mitochondrial outer membraneBH3-interacting domain death agonistHomo sapiens (human)
cytosolBH3-interacting domain death agonistHomo sapiens (human)
membraneBH3-interacting domain death agonistHomo sapiens (human)
mitochondrionBH3-interacting domain death agonistHomo sapiens (human)
cytosolBH3-interacting domain death agonistHomo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
cytoplasmBcl-2-like protein 1Homo sapiens (human)
mitochondrionBcl-2-like protein 1Homo sapiens (human)
mitochondrial outer membraneBcl-2-like protein 1Homo sapiens (human)
mitochondrial inner membraneBcl-2-like protein 1Homo sapiens (human)
mitochondrial matrixBcl-2-like protein 1Homo sapiens (human)
endoplasmic reticulumBcl-2-like protein 1Homo sapiens (human)
centrosomeBcl-2-like protein 1Homo sapiens (human)
cytosolBcl-2-like protein 1Homo sapiens (human)
synaptic vesicle membraneBcl-2-like protein 1Homo sapiens (human)
nuclear membraneBcl-2-like protein 1Homo sapiens (human)
Bcl-2 family protein complexBcl-2-like protein 1Homo sapiens (human)
mitochondrial outer membraneBcl-2-like protein 1Homo sapiens (human)
nucleusInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
nucleoplasmInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
cytoplasmInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
mitochondrionInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
mitochondrial outer membraneInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
cytosolInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
membraneInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
Bcl-2 family protein complexInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
mitochondrial outer membraneInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
mitochondrial outer membraneBcl-2 homologous antagonist/killerHomo sapiens (human)
mitochondrionBcl-2 homologous antagonist/killerHomo sapiens (human)
mitochondrial outer membraneBcl-2 homologous antagonist/killerHomo sapiens (human)
endoplasmic reticulumBcl-2 homologous antagonist/killerHomo sapiens (human)
cytosolBcl-2 homologous antagonist/killerHomo sapiens (human)
Bcl-2 family protein complexBcl-2 homologous antagonist/killerHomo sapiens (human)
BAK complexBcl-2 homologous antagonist/killerHomo sapiens (human)
pore complexBcl-2 homologous antagonist/killerHomo sapiens (human)
Elg1 RFC-like complexATPase family AAA domain-containing protein 5Homo sapiens (human)
nucleusATPase family AAA domain-containing protein 5Homo sapiens (human)
cytoplasmAtaxin-2Homo sapiens (human)
Golgi apparatusAtaxin-2Homo sapiens (human)
trans-Golgi networkAtaxin-2Homo sapiens (human)
cytosolAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
membraneAtaxin-2Homo sapiens (human)
perinuclear region of cytoplasmAtaxin-2Homo sapiens (human)
ribonucleoprotein complexAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (60)

Assay IDTitleYearJournalArticle
AID1503774Cytotoxicity against human HL cells assessed as cell viability at 50 uM after 72 hrs by resazurin dye based fluorescence assay relative to control2017Journal of natural products, 10-27, Volume: 80, Issue:10
Identification of Privileged Antichlamydial Natural Products by a Ligand-Based Strategy.
AID399390Antiplatelet activity in human whole blood assessed as inhibition of ristocetin-induced platelet aggregation at 100 ug/mL relative to control1998Journal of natural products, Jan, Volume: 61, Issue:1
A new antiplatelet diarylheptanoid from Alpinia blepharocalyx.
AID666150Inhibition of PA endonuclease at 10 uM2011PloS one, , Volume: 6, Issue:5
Anti-influenza activity of marchantins, macrocyclic bisbibenzyls contained in liverworts.
AID1090307Antifungal activity against Hypocrea rufa assessed as growth inhibition at 10 ppm after 4 days relative to untreated control2006Journal of agricultural and food chemistry, Feb-08, Volume: 54, Issue:3
Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum).
AID732687Antitubercular activity against Mycobacterium tuberculosis assessed as growth inhibition2013Bioorganic & medicinal chemistry letters, Mar-01, Volume: 23, Issue:5
Syntheses of lipophilic chalcones and their conformationally restricted analogues as antitubercular agents.
AID1090302Herbicidal activity against Lactuca sativa cv. Great Lakes 366 (lettuce) assessed as inhibition of root length at 1 ppm relative to untreated control2006Journal of agricultural and food chemistry, Feb-08, Volume: 54, Issue:3
Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum).
AID399389Antiplatelet activity in human whole blood assessed as inhibition of arachidonic acid-induced platelet aggregation at 100 ug/mL relative to control1998Journal of natural products, Jan, Volume: 61, Issue:1
A new antiplatelet diarylheptanoid from Alpinia blepharocalyx.
AID644368Antiprotozoal activity against erythrocytic stages chloroquine- and pyrimethamine-resistant Plasmodium falciparum K1 assessed as inhibition of [3H]hypoxanthine incorporation pre-incubated for 48 hrs prior [3H]hypoxanthine addition measured after 24 hrs by2012Bioorganic & medicinal chemistry, Feb-15, Volume: 20, Issue:4
Synthesis and antimalarial and antituberculosis activities of a series of natural and unnatural 4-methoxy-6-styryl-pyran-2-ones, dihydro analogues and photo-dimers.
AID1090303Herbicidal activity against Lactuca sativa cv. Great Lakes 366 (lettuce) assessed as inhibition of shoot length at 10 ppm relative to untreated control2006Journal of agricultural and food chemistry, Feb-08, Volume: 54, Issue:3
Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum).
AID1105552Antifungal activity against Athelia rolfsii assessed as growth inhibition at 1000 ppm by agar dilution method relative to control1996Bioscience, biotechnology, and biochemistry, Oct, Volume: 60, Issue:10
Syntheses and biological activities of dihydro-5,6-dehydrokawain derivatives.
AID644370Selectivity index, ratio of IC50 for erythrocytic stages chloroquine and pyrimethamine-resistant Plasmodium falciparum K1 to IC50 for rat L6 myoblasts2012Bioorganic & medicinal chemistry, Feb-15, Volume: 20, Issue:4
Synthesis and antimalarial and antituberculosis activities of a series of natural and unnatural 4-methoxy-6-styryl-pyran-2-ones, dihydro analogues and photo-dimers.
AID1090314Antifungal activity against Colletotrichum gloeosporioides assessed as growth inhibition at 10 ppm after 4 days relative to untreated control2006Journal of agricultural and food chemistry, Feb-08, Volume: 54, Issue:3
Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum).
AID1450308Osteogenic activity in mouse MC3T3-E1 cells assessed as increase in mineralization at 60 uM measured after 10 days by alizarin red S staining based assay2017Bioorganic & medicinal chemistry letters, 06-01, Volume: 27, Issue:11
Synthesis of novel 5,6-dehydrokawain analogs as osteogenic inducers and their action mechanisms.
AID644364Antituberculosis activity against Mycobacterium tuberculosis H37Rv after 7 to 14 days by twofold serial broth dilution method2012Bioorganic & medicinal chemistry, Feb-15, Volume: 20, Issue:4
Synthesis and antimalarial and antituberculosis activities of a series of natural and unnatural 4-methoxy-6-styryl-pyran-2-ones, dihydro analogues and photo-dimers.
AID1090306Herbicidal activity against Lactuca sativa cv. Great Lakes 366 (lettuce) assessed as inhibition of germination at 1 ppm relative to untreated control2006Journal of agricultural and food chemistry, Feb-08, Volume: 54, Issue:3
Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum).
AID1105554Antifungal activity against Athelia rolfsii assessed as growth inhibition at 100 ppm by agar dilution method relative to control1996Bioscience, biotechnology, and biochemistry, Oct, Volume: 60, Issue:10
Syntheses and biological activities of dihydro-5,6-dehydrokawain derivatives.
AID1504726Cytotoxicity against human KB cells up to 10 uM2017Journal of natural products, 12-22, Volume: 80, Issue:12
(+)- and (-)-Ecarlottones, Uncommon Chalconoids from Fissistigma latifolium with Pro-Apoptotic Activity.
AID1105555Antifungal activity against Pythium sp. assessed as growth inhibition at 100 ppm by agar dilution method relative to control1996Bioscience, biotechnology, and biochemistry, Oct, Volume: 60, Issue:10
Syntheses and biological activities of dihydro-5,6-dehydrokawain derivatives.
AID447716Hepatotoxicity against mouse Hepa-1c1c7 cells after 48 hrs by celltiter blue assay2009Bioorganic & medicinal chemistry letters, Oct-01, Volume: 19, Issue:19
Identification of methysticin as a potent and non-toxic NF-kappaB inhibitor from kava, potentially responsible for kava's chemopreventive activity.
AID1090301Herbicidal activity against Lactuca sativa cv. Great Lakes 366 (lettuce) assessed as inhibition of root length at 10 ppm relative to untreated control2006Journal of agricultural and food chemistry, Feb-08, Volume: 54, Issue:3
Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum).
AID358852Antiproliferative activity against mouse Colon 26-L5 cells by MTT assay2001Journal of natural products, Mar, Volume: 64, Issue:3
Six new diarylheptanoids from the seeds of Alpinia blepharocalyx.
AID399388Antiplatelet activity in human whole blood assessed as inhibition of ADP-induced platelet aggregation at 100 ug/mL relative to control1998Journal of natural products, Jan, Volume: 61, Issue:1
A new antiplatelet diarylheptanoid from Alpinia blepharocalyx.
AID449984Induction of DR5 receptor promotor activity in human DLD1 cells co-transfected with Sac1 at 39 uM after 24 hrs by luciferase assay2009Bioorganic & medicinal chemistry, Sep-15, Volume: 17, Issue:18
Death receptor 5 promoter-enhancing compounds isolated from Catimbium speciosum and their enhancement effect on TRAIL-induced apoptosis.
AID1090316Herbicidal activity against Echinochloa crus-galli (barnyard grass) assessed as inhibition of root length at 1 ppm relative to untreated control2006Journal of agricultural and food chemistry, Feb-08, Volume: 54, Issue:3
Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum).
AID1450315Cytotoxicity against mouse MC3T3-E1 cells assessed as cell number at 60 uM measured after 4 days by WST-8 assay relative to control2017Bioorganic & medicinal chemistry letters, 06-01, Volume: 27, Issue:11
Synthesis of novel 5,6-dehydrokawain analogs as osteogenic inducers and their action mechanisms.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1450307Osteogenic activity in mouse MC3T3-E1 cells assessed as increase in ALP activity at 60 uM measured after 4 days relative to control2017Bioorganic & medicinal chemistry letters, 06-01, Volume: 27, Issue:11
Synthesis of novel 5,6-dehydrokawain analogs as osteogenic inducers and their action mechanisms.
AID1090308Antifungal activity against Hypocrea rufa assessed as growth inhibition at 50 ppm after 4 days relative to untreated control2006Journal of agricultural and food chemistry, Feb-08, Volume: 54, Issue:3
Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum).
AID1090313Antifungal activity against Colletotrichum gloeosporioides assessed as growth inhibition at 50 ppm after 4 days relative to untreated control2006Journal of agricultural and food chemistry, Feb-08, Volume: 54, Issue:3
Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum).
AID1503775Antichlamydial activity against Chlamydia pneumoniae K7 infected in HL cells assessed as chlamydial inhibition at 50 uM after 70 hrs by fluorescent microscopic analysis2017Journal of natural products, 10-27, Volume: 80, Issue:10
Identification of Privileged Antichlamydial Natural Products by a Ligand-Based Strategy.
AID1090304Herbicidal activity against Lactuca sativa cv. Great Lakes 366 (lettuce) assessed as inhibition of shoot length at 1 ppm relative to untreated control2006Journal of agricultural and food chemistry, Feb-08, Volume: 54, Issue:3
Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum).
AID1090310Antifungal activity against Fusarium oxysporum assessed as growth inhibition at 10 ppm after 4 days relative to untreated control2006Journal of agricultural and food chemistry, Feb-08, Volume: 54, Issue:3
Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum).
AID358853Antiproliferative activity against human HT1080 cells by MTT assay2001Journal of natural products, Mar, Volume: 64, Issue:3
Six new diarylheptanoids from the seeds of Alpinia blepharocalyx.
AID644367Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigotes after 72 hrs by alamar blue assay2012Bioorganic & medicinal chemistry, Feb-15, Volume: 20, Issue:4
Synthesis and antimalarial and antituberculosis activities of a series of natural and unnatural 4-methoxy-6-styryl-pyran-2-ones, dihydro analogues and photo-dimers.
AID1450306Inhibition of RANKL-stimulated osteoclastogenesis in mouse RAW264 cells assessed as reduction in TRAP activity at 20 uM measured after 72 hrs by microscopic analysis2017Bioorganic & medicinal chemistry letters, 06-01, Volume: 27, Issue:11
Synthesis of novel 5,6-dehydrokawain analogs as osteogenic inducers and their action mechanisms.
AID644366Antiprotozoal activity against Trypanosoma cruzi Tulahuen C2C4 amastigotes infected in rat L6 myoblasts after 96 hrs by CPRG/Nonidet-based spectrophotometry2012Bioorganic & medicinal chemistry, Feb-15, Volume: 20, Issue:4
Synthesis and antimalarial and antituberculosis activities of a series of natural and unnatural 4-methoxy-6-styryl-pyran-2-ones, dihydro analogues and photo-dimers.
AID449985Induction of DR5 receptor promotor activity in human DLD1 cells co-transfected with Sac1 at 43.9 uM after 24 hrs by luciferase assay2009Bioorganic & medicinal chemistry, Sep-15, Volume: 17, Issue:18
Death receptor 5 promoter-enhancing compounds isolated from Catimbium speciosum and their enhancement effect on TRAIL-induced apoptosis.
AID1090311Antifungal activity against Fusarium solani assessed as growth inhibition at 50 ppm after 4 days relative to untreated control2006Journal of agricultural and food chemistry, Feb-08, Volume: 54, Issue:3
Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum).
AID311568Cytotoxicity against human PANC1 cells assessed as cell viability2007Journal of natural products, Oct, Volume: 70, Issue:10
Bioactive secondary metabolites from Boesenbergia pandurata of Myanmar and their preferential cytotoxicity against human pancreatic cancer PANC-1 cell line in nutrient-deprived medium.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1090298Herbicidal activity against Echinochloa crus-galli (barnyard grass) assessed as inhibition of shoot length at 1 ppm relative to untreated control2006Journal of agricultural and food chemistry, Feb-08, Volume: 54, Issue:3
Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum).
AID1105553Antifungal activity against Pythium sp. assessed as growth inhibition at 1000 ppm by agar dilution method relative to control1996Bioscience, biotechnology, and biochemistry, Oct, Volume: 60, Issue:10
Syntheses and biological activities of dihydro-5,6-dehydrokawain derivatives.
AID1450314Cytotoxicity against mouse MC3T3-E1 cells assessed as cell number at 30 uM measured after 4 days by WST-8 assay relative to control2017Bioorganic & medicinal chemistry letters, 06-01, Volume: 27, Issue:11
Synthesis of novel 5,6-dehydrokawain analogs as osteogenic inducers and their action mechanisms.
AID1504723Inhibition of His-tagged Bcl-xL (unknown origin)/5-carboxyfluorescein-labeled Bak (unknown origin) protein protein interaction after 1 hr by fluorescence polarization assay2017Journal of natural products, 12-22, Volume: 80, Issue:12
(+)- and (-)-Ecarlottones, Uncommon Chalconoids from Fissistigma latifolium with Pro-Apoptotic Activity.
AID1090315Herbicidal activity against Echinochloa crus-galli (barnyard grass) assessed as inhibition of root length at 10 ppm relative to untreated control2006Journal of agricultural and food chemistry, Feb-08, Volume: 54, Issue:3
Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum).
AID1090300Herbicidal activity against Echinochloa crus-galli (barnyard grass) assessed as inhibition of germination at 1 ppm relative to untreated control2006Journal of agricultural and food chemistry, Feb-08, Volume: 54, Issue:3
Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum).
AID1090299Herbicidal activity against Echinochloa crus-galli (barnyard grass) assessed as inhibition of germination at 10 ppm relative to untreated control2006Journal of agricultural and food chemistry, Feb-08, Volume: 54, Issue:3
Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum).
AID1090305Herbicidal activity against Lactuca sativa cv. Great Lakes 366 (lettuce) assessed as inhibition of germination at 10 ppm relative to untreated control2006Journal of agricultural and food chemistry, Feb-08, Volume: 54, Issue:3
Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum).
AID399387Antiplatelet activity in human whole blood assessed as inhibition of collagen-induced platelet aggregation at 100 ug/mL relative to control1998Journal of natural products, Jan, Volume: 61, Issue:1
A new antiplatelet diarylheptanoid from Alpinia blepharocalyx.
AID1504724Inhibition of His-tagged MCL1 (unknown origin)/5-carboxyfluorescein-labeled Bid (unknown origin) protein protein interaction after 1 hr by fluorescence polarization assay2017Journal of natural products, 12-22, Volume: 80, Issue:12
(+)- and (-)-Ecarlottones, Uncommon Chalconoids from Fissistigma latifolium with Pro-Apoptotic Activity.
AID1504725Cytotoxicity against HEK293 cells up to 10 uM2017Journal of natural products, 12-22, Volume: 80, Issue:12
(+)- and (-)-Ecarlottones, Uncommon Chalconoids from Fissistigma latifolium with Pro-Apoptotic Activity.
AID1754626Inhibition of Wnt signalling in HEK293 cells harbouring TCF/beta-catenin luciferase reporter gene assessed as TCF/beta-catenin transcriptional activity at 30 to 60 uM by TOPFlash luciferase assay2021Bioorganic & medicinal chemistry letters, 08-01, Volume: 45Linderapyrone: A Wnt signal inhibitor isolated from Lindera umbellata.
AID1090309Antifungal activity against Fusarium oxysporum assessed as growth inhibition at 50 ppm after 4 days relative to untreated control2006Journal of agricultural and food chemistry, Feb-08, Volume: 54, Issue:3
Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum).
AID447711Inhibition of TNF-alpha-induced NF-kappaB expressed in human A549 cells treated 1 hr after TNFalpha challenge measured after 6 hrs by luciferase reporter gene assay2009Bioorganic & medicinal chemistry letters, Oct-01, Volume: 19, Issue:19
Identification of methysticin as a potent and non-toxic NF-kappaB inhibitor from kava, potentially responsible for kava's chemopreventive activity.
AID644369Cytotoxicity against rat L6 myoblasts after 72 hrs by alamar blue assay2012Bioorganic & medicinal chemistry, Feb-15, Volume: 20, Issue:4
Synthesis and antimalarial and antituberculosis activities of a series of natural and unnatural 4-methoxy-6-styryl-pyran-2-ones, dihydro analogues and photo-dimers.
AID644365Antiprotozoal activity against Trypanosoma brucei rhodesiense STIB900 trypomastigotes after 72 hrs by alamar blue assay2012Bioorganic & medicinal chemistry, Feb-15, Volume: 20, Issue:4
Synthesis and antimalarial and antituberculosis activities of a series of natural and unnatural 4-methoxy-6-styryl-pyran-2-ones, dihydro analogues and photo-dimers.
AID1450313Osteogenic activity in mouse MC3T3-E1 cells assessed as increase in mineralization at 0.1 to 60 uM measured after 10 days by alizarin red S staining based assay2017Bioorganic & medicinal chemistry letters, 06-01, Volume: 27, Issue:11
Synthesis of novel 5,6-dehydrokawain analogs as osteogenic inducers and their action mechanisms.
AID666151Inhibition of PA endonuclease at 1 uM2011PloS one, , Volume: 6, Issue:5
Anti-influenza activity of marchantins, macrocyclic bisbibenzyls contained in liverworts.
AID1090317Herbicidal activity against Echinochloa crus-galli (barnyard grass) assessed as inhibition of shoot length at 10 ppm relative to untreated control2006Journal of agricultural and food chemistry, Feb-08, Volume: 54, Issue:3
Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum).
AID1090312Antifungal activity against Fusarium solani assessed as growth inhibition at 10 ppm after 4 days relative to untreated control2006Journal of agricultural and food chemistry, Feb-08, Volume: 54, Issue:3
Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (40)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (2.50)18.7374
1990's5 (12.50)18.2507
2000's12 (30.00)29.6817
2010's21 (52.50)24.3611
2020's1 (2.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 19.18

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index19.18 (24.57)
Research Supply Index3.71 (2.92)
Research Growth Index5.26 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (19.18)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other40 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]